SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

29 Apr 2024 Evaluate
The Revenue for the quarter ended  March 2024 of Rs. 3138.04 millions grew by 19.03 % from Rs. 2636.42 millions.The Company has registered profit of Rs. 261.68  millions for the quarter ended March 2024, a growth of 13.09%  over Rs. 231.39 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2024 rose to 430.63 millions as compared to 381.08 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3138.04 2636.42 19.03 12029.10 9751.72 23.35 12029.10 9751.72 23.35
Other Income 13.42 23.19 -42.13 67.71 35.98 88.19 67.71 35.98 88.19
PBIDT 430.63 381.08 13.00 1680.25 1262.46 33.09 1680.25 1262.46 33.09
Interest 17.38 11.63 49.44 97.02 46.18 110.09 97.02 46.18 110.09
PBDT 413.25 369.45 11.86 1583.23 1216.28 30.17 1583.23 1216.28 30.17
Depreciation 65.80 67.16 -2.03 241.89 259.83 -6.90 241.89 259.83 -6.90
PBT 347.45 302.29 14.94 1341.34 956.45 40.24 1341.34 956.45 40.24
TAX 85.77 70.90 20.97 344.89 242.55 42.19 344.89 242.55 42.19
Deferred Tax 1.70 -9.27 -118.34 -16.70 -17.11 -2.40 -16.70 -17.11 -2.40
PAT 261.68 231.39 13.09 996.45 713.90 39.58 996.45 713.90 39.58
Equity 110.49 110.31 0.16 110.49 110.31 0.16 110.49 110.31 0.16
PBIDTM(%) 13.72 14.45 -5.06 13.97 12.95 7.90 13.97 12.95 7.90

Rossari Biotech Share Price

483.60 4.85 (1.01%)
04-May-2026 11:29 View Price Chart
Peers
Company Name CMP
BASF India 3709.95
Tata Chemicals 820.50
SRF 2558.20
Pidilite Inds. 1383.70
Deepak Nitrite 1736.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×